NMRA News
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2026-08-14 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 2.02,5.02,9.01. |
| 2026-07-27 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2026-06-15 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 1.01,2.03,2.05,7.01,8.01,9.01. |
| 2026-05-29 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 5.07. |
| 2026-05-07 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2026-03-30 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2026-02-11 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2026-01-12 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2026-01-05 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2025-11-21 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 3.02,9.01. |
| 2025-11-06 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-10-27 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2025-10-27 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2025-08-06 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-05-30 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 5.07. |
| 2025-05-16 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 3.01. |
| 2025-05-12 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-04-11 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K/A | Neumora Therapeutics, Inc. filed Form 8-K/A covering items 5.02. |
| 2025-03-03 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-02-21 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K/A | Neumora Therapeutics, Inc. filed Form 8-K/A covering items 5.02. |
| 2025-02-13 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 5.02,7.01,9.01. |
| 2025-01-13 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2025-01-02 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2024-11-12 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-08-06 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-06-14 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 5.07. |
| 2024-05-07 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-04-15 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 8.01. |
| 2024-03-07 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-01-08 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2023-11-28 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2023-11-01 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2023-09-19 | Current report | SEC filing | Neumora Therapeutics, Inc. filed Form 8-K | Neumora Therapeutics, Inc. filed Form 8-K covering items 5.03,8.01,9.01. |